公司資料
Endologix 股價、新聞與催化劑
- 股票代碼:
- ELGXQ
- 交易所:
- NASDAQ
- 產業:
- MedTech
- 所在地:
- United States and traded publicly before its bankruptcy or legacy status
股價為何變動
Current closing-price context is not available for ELGXQ.
公司概覽
業務概覽
Endologix was a medical device company focused on endovascular and vascular repair systems before becoming a historical ticker. Its business was tied to procedure-based vascular technology rather than therapeutics.
所在地與產業分類
Endologix was headquartered in the United States and traded publicly before its bankruptcy or legacy status. It sat in vascular medtech.
商業模式特徵
The company depended on device adoption, hospital relationships, and commercial execution in a specialized vascular market. Investors historically watched product cycles and operational turnaround.
生技產業定位
Endologix belongs to the historical vascular-device category. It is outside biotech and more tied to procedural medtech and hospital adoption.
未來催化劑
- Endologix is a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a fresh medtech milestone. The market is focused on residual value.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。